5-HT2 Receptor Antagonism Reduces Hyperactivity Induced by Amphetamine, Cocaine, and MK-801 But Not D1 Agonist C-APB

This publication has 31 references indexed in Scilit:

• Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice
  Psychopharmacology, 1997
• Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine
  Neuropsychopharmacology, 1996
• The selective 5-HT2a receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse ? implications for psychosis
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1995
• Ritanserin, a Selective 5-HT_2/1CAntagonist, and Negative Symptoms in Schizophrenia
  The British Journal of Psychiatry, 1993
• Recent advances in the phencyclidine model of schizophrenia
  American Journal of Psychiatry, 1991
• Clozapine
  Drugs, 1990
• The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
• Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
  Synapse, 1987
• Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice
  Neuropharmacology, 1984
• Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
  Drug Development Research, 1982